Is Dopamine Agonist Therapy Associated with Developing Pathological Gambling in Parkinson’s Disease Patients?

Publisher： Karger

E-ISSN： 1421-9913|59|3-4|183-186

ISSN： 0014-3022

Source： European Neurology, Vol.59, Iss.3-4, 2008-01, pp. : 183-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety and Tolerability of Pardoprunox, a New Partial Dopamine Agonist, in a Randomized, Controlled Study of Patients with Advanced Parkinson’s Disease

By  

European Neurology, Vol. 62, Iss. 1, 2009-04 ,pp. : 40-48

Karger

Access to resources Recommend Favorite

The ACE Deletion Polymorphism Is Not Associated with Parkinson’s Disease

By  

European Neurology, Vol. 41, Iss. 2, 1999-02 ,pp. : 103-106

Karger

Access to resources Recommend Favorite

Cortical Serotonin 1A Receptor Levels Are Associated with Depression in Patients with Dementia with Lewy Bodies and Parkinson’s Disease Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 26, Iss. 4, 2008-10 ,pp. : 330-338

Karger

Access to resources Recommend Favorite

Pain Perception, Pain Drug Therapy and Health Status in Patients with Parkinson’s Disease

By  

Neuroepidemiology, Vol. 37, Iss. 3-4, 2011-11 ,pp. : 183-187

Karger

Access to resources Recommend Favorite

Melatonin and parkinson’s disease

By Mayo Juan   Sainz Rosa   Tan Dun-Xian   Antolín Isaac   Rodríguez Carmen   Reiter Russel  

Endocrine Journal, Vol. 27, Iss. 2, 2005-07 ,pp. : 169-178

Humana Press, Inc

Access to resources Recommend Favorite